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Fig. S1. Structures of the amino acids and probes used in this study.  
 
  
 
 
Fig. S2. Selective aminoacylation of initiator tRNA by EcMetRS. Synthetically 
prepared tRNAs tested with EcNLL-MetRS and Anl. The formation of Anl-tRNAs 
was examined by conjugation of DIFO-AlexaFluor488 to Anl residues followed by 
fluorescence scanning of agarose gels. The NLL-EcMetRS, like the wild-type E. 
coli MetRS, does not charge eukaryotic cytoplasmic elongator-tRNAMet. 
 
  
 
 
Fig. S3. NLL-EcMetRS is expressed as a full-length fusion with mCherry in 
the HEK293-8D3 cytoplasm. (A) The gene construct used to express a His-
tagged NLL-EcMetRS-mCherry fusion (91.4 kDa). The DNA sequence for the 
bacterial synthetase was originally derived from the E. coli genome and 
expressed in truncated form (Δ548) with mutations corresponding to L13N/ 
Y260L/H301L, which were generated by site-directed mutagenesis. (B) HEK293-
8D3 cells exhibit broadly distributed fluorescence associated with expression of 
NLL-EcMetRS-mCherry. (C) Affinity purification of NLL-EcMetRS-mCherry from 
cytosolic proteins via its N-terminal His-tag verified that the protein was soluble 
and localized to the cytosol. (D) Western analysis of cytosolic proteins with anti-
DsRed antibody for detection of C-terminal mCherry further confirmed that the 
protein fusion was fully intact following expression of the bacterial gene. 
 
Fig. S4. Cysteine alkylation with iodoacetamide eliminates the background 
reaction of DIBAC-probes with protein thiols. (A) Histone H3 (the only histone 
that contains cysteine) from unlabeled cells was modified with DIBAC-TAMRA. 
The background reaction was eliminated following alkylation of cysteine with 
iodoacetamide. (B) Recombinant DHFR does not contain cysteine and unlabeled 
DHFR was not modified with DIBAC-TAMRA. A DHFR containing 7 Anl residues 
was modified with DIBAC-TAMRA; a complete band shift of the protein indicated 
that the reaction was efficient. (C) The background reaction between DIBAC-
TAMRA and unlabeled proteins in cell lysates was eliminated following alkylation 
of cysteines with iodoacetamide. (D) DIBAC-TAMRA labeling is highly specific for 
Anl-labeled proteins following alkylation with iodoacetamide. A comparison with 
proteins not exposed to DIBAC-TAMRA is shown. 
 
 
Fig. S5. Quantification of TAMRA intensity on proteins from cells pulsed for 
various times and with various concentration of Anl. (A)Labeled proteins 
could be detected from HEK293-8D3 cells following a 15 m pulse with 1 mM Anl; 
the amount of labeled protein increased as the pulse length was extended to 4 h. 
Proteins were not labeled in HEK293 cells treated with a mM Anl for 4 h. (B) 
Labeled proteins could be detected from HEK293-8D3 cells pulse-labeled with 
15.625 µM Anl for 4 h; the extent of labeling increased as the Anl concentration 
was raised. Proteins were not labeled in HEK293 cells treated with 2 mM Anl for 
the same time. 
 
  
 
 
Fig. S6. Enrichment of labeled proteins. (A) Lysates from pulsed non-
transfected cells (“mock enrichment”) and pulsed HEK293-8D3 cells were treated 
with DIBAC-biotin (input, “I”), and biotinylated proteins were collected on 
immobilized streptavidin. The unbound fraction (flow-through, “FT”), and final 
wash “FW” were collected and compared to the elution “E.” The enrichments 
were followed using Coomassie staining of SDS-PAGE gels and parallel 
detection of biotinylated proteins via Western blot with fluorescent streptavidin. 
(B) The extent of enrichment was estimated using purified GFPs (28.2 kDa) 
containing a single Anl or Met, which were mixed with unlabeled lysate at a ratio 
of 1:1,000 (GFP:lysate, w/w). The mixtures were subjected to the enrichment 
procedure using DIBAC-biotin and the extent of enrichment (more than 500-fold) 
was determined by comparing initial mixtures with eluted fractions. 
 
 
 
Fig. S7. Structures, masses, and formulas of the Anl-derived modifications 
used as variable substitutions in the peptide identification search.   
 
  
 
 
Fig. S8. Detection of N-terminal Anl residues by mass spectrometry. (A) Ion 
fragmentation spectrum of the N-terminal tryptic peptide of PTBP-1 containing 
modified Anl. Mass shifts corresponding to Nα-acetylation of Anl (+42) and 
modification with DIBAC-biotin (+676) are shown relative to Met (M). (B) 
Spectrum of the N-terminal peptide of 14-3-3 protein ε, which was identified by 
analysis of proteins enriched after treatment with DIBAC-S-S-biotin. The mass 
shifts caused by Nα-acetylation of Anl and by modification with the reduced and 
alkylated probe (+444) are shown relative to Met. Additional spectra of peptides 
containing N-terminal Anl modification are provided in Fig. S10. 
  
 
 
Fig. S9. Comparison of DIBAC-biotin and DIBAC-S-S-biotin.  DIBAC-biotin 
and DIBAC-S-S-biotin specifically labeled Anl side chains in the absence of free 
thiols. The model DHFR used as the labeling substrate does not contain cysteine 
residues. 
 
  
 
 
Fig. S10. Spectra of additional N-terminal peptides identified with Anl 
modifications. 
 
  
 
 
Fig. S10 (continued) Spectra of additional N-terminal peptides identified 
with Anl modifications. 
 
  
 
 
Fig. S11. MetAP exhibits attenuated excision activity toward N-terminal Anl. 
(A) Structures of fluorogenic model substrates tested with recombinant MetAP-2. 
(B) Saturation curves of Met-AMC and Anl-AMC in reaction with recombinant 
MetAP-2. Kinetic constants for the Met-AMC substrate were: Km = 124 μM, kcat = 
31.19 s-1, kcat/Km = 0.26 s-1μM. For Anl-AMC: Km = 111 μM, kcat = 9.59 s-1, kcat/Km 
= 0.33 s-1μM. (C) Comparison of Anl-labeled proteins from cells treated with Anl 
in the presence or absence of 200 nM fumagillin, an irreversible MetAP-2 
inhibitor. 
 
  
 
 
Fig. S12. Effect of HU on histone synthesis. HEK293-8D3 cells were pulsed 
with 1 mM Anl in the absence (black) or presence (red) of 4 mM HU, or treated 
with 4 mM HU and released from the agent 10 minutes before the pulse (blue). 
Following extraction of histones, proteins were modified with DIBAC-TAMRA and 
quantified by in-gel fluorescence scanning. 
 
  
Protein Protein Accession 
Number 
Met AP Substrate 
GRB2 Isoform 1 of Growth factor receptor-
bound protein 2 
IPI00021327 No 
SYNGR2 Synaptogyrin-2 IPI00013946, 
IPI00654744, 
IPI00789763 
No 
HIST1H1C Histone H1.2 IPI00217465 Yes 
YWHAB Isoform Short of 14-3-3 protein 
beta/alpha 
IPI00759832 Partial 
YWHAE 14-3-3 protein epsilon IPI00000816 No 
YWHAZ 14-3-3 protein zeta/delta IPI00021263 No 
SLC25A5 ADP/ATP translocase 2 IPI00007188 Yes 
EIF3I Eukaryotic translation initiation 
factor 3 subunit I 
IPI00012795 No 
TUBB2C Tubulin beta-2C chain IPI00007752 No 
STIP1 Stress-induced-phosphoprotein 1 IPI00013894, 
IPI00871856 
No 
EEF2 Elongation factor 2 IPI00186290 Yes 
PTBP1 polypyrimidine tract-binding 
protein 1 isoform a 
IPI00183626, 
IPI00334175 
No 
 
Table S1. N-terminal peptides that contain Anl are derived both from 
proteins that are substrates of MetAPs, and from proteins that are not. 
 	   	  
Protein Protein Accession 
Number 
N-α-acetyl-Met N-α-acetyl-Anl 
GRB2 Isoform 1 of Growth factor receptor-
bound protein 2 
IPI00021327 Yes Yes 
SYNGR2 Synaptogyrin-2 IPI00013946, 
IPI00654744, 
IPI00789763 
Yes Yes 
HIST1H1C Histone H1.2 IPI00217465 n/a No 
YWHAB Isoform Short of 14-3-3 protein 
beta/alpha 
IPI00759832 Yes Yes 
YWHAE 14-3-3 protein epsilon IPI00000816 Yes Yes 
YWHAZ 14-3-3 protein zeta/delta IPI00021263 Yes Yes 
SLC25A5 ADP/ATP translocase 2 IPI00007188 n/a No 
EIF3I Eukaryotic translation initiation 
factor 3 subunit I 
IPI00012795 No No 
TUBB2C Tubulin beta-2C chain IPI00007752 No No 
STIP1 Stress-induced-phosphoprotein 1 IPI00013894, 
IPI00871856 
Yes Yes 
EEF2 Elongation factor 2 IPI00186290 n/a No 
PTBP1 polypyrimidine tract-binding 
protein 1 isoform a 
IPI00183626, 
IPI00334175 
Yes Yes 
 
Table S2. N-terminal peptides identified with Anl in place of Met are 
properly Nα-acetylated. 
 
 
 
 
  
SUPPORTING INFORMATION MATERIALS AND METHODS: 
 
Tagging and Detection Reagents 
All materials from commercial suppliers were used without further purification 
unless otherwise indicated. Anl was synthesized as previously described (1) 
(using Nα-Boc-L-lysine in place of Nα-Boc-L-diaminobutyric acid as the starting 
material) and verified by 1H NMR and mass spectrometry. Anl is commercially 
available and can be purchased from Jena Bioscience (as 6-azido-L-lysine HCl), 
and from MolPort (as (2S)-2-amino-6-azidohexanoic acid hydrochloride). DIBAC-
TAMRA, DIBAC-Biotin, and DIBAC-S-S-biotin were purchased from Click 
Chemistry Tools (see Fig. S1 for structures). The Click-iT AlexaFluor488 Protein 
Synthesis HCS Assay was purchased from Life Technologies. [13C6, 15N2]-lysine 
was purchased from Cambridge Isotopes. 
 
Anl Labeling Procedure 
HEK293 cells were grown in Dulbeccoʼs Modified Eagle Medium containing 10% 
fetal bovine serum (FBS), penicillin and streptomycin, and 50 μg mL-1 geneticin 
at 37°C, with 5% CO2 using standard procedures. The culture medium was 
exchanged with fresh medium either several hours or the night before each 
experiment. Cells at 70 – 80% confluence were labeled by addition of Anl to the 
culture medium at the indicated concentrations and incubated for the indicated 
times at 37°C under 5% CO2. Labeling was terminated by aspiration of the 
culture medium, and cells were washed with phosphate buffered saline (PBS) 
and collected by trypsinization and centrifugation. Pelleted cells were washed 
with PBS to remove trypsin and stored at -20°C until further processing.  
 
Preparation of Cell Lysates 
Cell pellets were re-suspended in 100 mM Tris buffer (pH 8.0) containing 
protease inhibitor cocktail (eComplete ETDA-free, Roche, 1 tablet/50 mL) and 
0.2% SDS (diluted from a 10% stock solution in water). Cells were lysed by 
pipetting and agitation, and chromosomal DNA was sheared by sonication on ice 
(three 10 s bursts at 9 W with 10 s pauses between bursts). Protein 
concentrations were determined using the BCA Protein Assay Kit (Pierce 
Biotechnology) and normalized to 1 mg mL-1 with lysis buffer. Free thiols were 
alkylated by adding iodoacetamide to a final concentration of 25 mM from a 
freshly prepared 500 mM stock in water; samples were mixed by gentle rotation 
for 1 h while protected from light. 
 
Protein Modification and Detection with DIBAC-functionalized Probes 
DIBAC-probe stocks (5 – 20 mM) were prepared in DMSO and conjugation 
reactions were initiated by dilution of probe into solutions of alkylated proteins to 
a final concentration of 20 μM. Reactions with DIBAC-TAMRA were incubated at 
room temperature for 20 m with gentle mixing and protection from light. 
Reactions with DIBAC-biotin and DIBAC-S-S-biotin were mixed gently at room 
temperature for 1 h. Reactions were quenched by addition of a five-fold excess 
(with respect to probe) of free Anl and immediately mixed by vortexing. 
 
Dye Labeling and Imaging 
HEK293-8D3 and non-transfected HEK293 cells were grown to ~75% confluence 
on 100 mm cell culture treated petri dishes, trypsinized and seeded in 8-well Lab-
Tek II Chamber Slides (ThermoScientific) at a density of ~2.5 x 104 cells per well. 
Cells were allowed to adhere overnight at 37°C under 5% CO2 in either 
293FreeStyle (Life Technologies) or maintenance medium (see Cell Culture 
Maintenance). Cells in 293FreeStyle medium were less adherent than those 
grown in maintenance medium. The following day, the medium was removed and 
replaced with pre-warmed medium with or without 1 mM Anl. For control 
experiments in which protein synthesis was inhibited, anisomycin was added to a 
final concentration of 40 μM 30 m prior to the Anl pulse and was included in the 
pulse at the same concentration. After 4 h, the medium was removed and cells 
were rinsed gently with PBS. Cells were fixed with 3% formaldehyde, 
permeabilized with 0.5% Triton X-100 in PBS, and labeled with the Click-iT Alexa 
Fluor 488 Protein Synthesis HCS Assay kit according to the manufacturerʼs 
protocol (Life Technologies). Cells were stained with Hoechst 33342 prior to 
imaging. For detection of mCherry, HEK293-8D3 and HEK293 cells from liquid 
suspension cultures in 293FreeStyle medium were plated in black-well clear-
bottom 96-well poly-D-Lysine plates (Fisher) at ~5 x 103 wells per well. Cells were 
allowed to adhere overnight and imaged the next day. Images were obtained on 
a Zeiss LSM510 microscope with 20X, 40X, or 63X (oil immersion) lenses. 
 
Enrichment of Anl-labeled Proteins 
T-75 flasks containing HEK293-8D3 or HEK293 cells at ~75% confluence were 
labeled with 2 mM Anl for 6 h. For labeling with heavy lysine, cells were rinsed 
once with lysine-free DMEM (Life Technologies) and then labeled in lysine-free 
DMEM supplemented with 800 µM [13C6, 15N2]-lysine and 2 mM Anl. Lysates 
were prepared as described above on a 2 mL scale and protein content (~6 mg) 
was normalized. Proteins were alkylated and conjugated to DIBAC-biotin as 
described above. Excess DIBAC-biotin was removed by two successive 
passages of the reaction mixture through PD-10 desalting columns equilibrated 
with 100 mM Tris buffer, pH 8.0 with 0.2% (w/v) SDS. The first passage was 
performed according to the “spin protocol;” the second passage was performed 
according to the “gravity flow” protocol described by the manufacturer. 
Biotinylated proteins were collected on Streptavidin Plus UltraLink Resin (Pierce 
Biotechnology) by adding 250 µL of the 50% slurry to each protein solution. 
Proteins were bound to the resin by gentle agitation of the suspension overnight 
at room temperature. The following day, the suspension was loaded into a 
disposable chromatography column and the flow-through was collected. The 
resin was washed once with 100 mM Tris buffer, pH 8.0 containing 0.2% (w/v) 
SDS; once with 100 mM Tris, pH 8.0 containing 1.0% (w/v) SDS; once with a 6 M 
urea solution in 100 mM Tris, pH 8.0; once with a 1 M NaCl solution in 100 mM 
Tris, pH 8.0; and once again with 100 mM Tris, pH 8.0 containing 0.2% (w/v) 
SDS. Each wash step was performed with 2.5 mL of solution and the entire wash 
procedure was performed twice before eluting resin-bound proteins by boiling in 
SDS-PAGE loading buffer containing 2% 2-mercaptoethanol (v/v) 
 
Hydroxyurea Treatment 
Hydroxyurea was added to cultures to a final concentration of 2.5 mM.  Anl was 
added to a concentration of 1 mM 10 m later. Cells were labeled with Anl for 4 h 
before proteins were collected and analyzed as described in preceding sections. 
 
Aminoacylation of synthetically prepared tRNA 
NLL-EcMetRS was expressed and purified as previously described (2) Synthetic 
tRNAs were prepared by the run-off transcript method and aminoacylated with 
Met or Anl as previously described (3). We tested cytoplasmic tRNAiMet and 
tRNAMet sequences from C. elegans (which are similar to the corresponding 
mammalian sequences); E. coli tRNAiMet and tRNAMet sequences were used as 
controls. Aminoacylated tRNAs were stabilized by acetic anyhydride as 
previously described (4). The tRNAs were precipitated with ice-cold 70% ethanol 
and resuspended in 100 mM Tris pH 7.0. Normalized tRNAs were labeled with 
DIFO-AlexaFluor488 (a gift from Carolyn Bertozzi, UC Berkeley) by incubation 
with 10 μM dye for 10 m. Excess dye was removed using BioSpin gel filtration 
columns (BioRad). tRNAs were separated on 2% aragose and imaged on a 
Typhoon Trio+ (GE Healthcare). 
 
Cloning 
The plasmid pmCherry-N1-His6-EcNLL-MetRS was constructed by inserting a 
gene encoding an N-terminally His-tagged NLL-EcMetRS between the XhoI and 
XmaI sites of the pmCherry-N1 vector (Clontech). pJS2-NLL is a bacterial 
expression vector for IPTG-induced expression of a His-tagged GFP encoding a 
single Met at the N-terminal position followed by an arginine. pJS2-NLL was 
cloned by inserting the NLL-EcMetRS expression cassette from pJTN1 (5) into 
pJS2 (6) at the NheI site.  
 
Generation of stable cell lines 
A 30 mL suspension culture of HEK293-F cells (Life Technologies) was grown to 
a density of 1 x 106 cells/mL in 293FreeStyle medium (Life Technologies) in a 
humidified incubator at 37°C with 8% CO2 and 130 rpm shaking. Cell were 
transfected with 150 μg of pmCherry-N1-His6-EcNLL-MetRS using 
polyethylenimine as the transfection reagent. The culture was allowed to grow for 
48 h at which point an aliquot of cells was inspected for mCherry fluorescence by 
microscopy. Roughly half the surviving cells exhibited mCherry fluorescence. A 
10 mL aliquot of the cell suspension was transferred to a T-75 culture flask and 
cells were allowed to adhere by incubation at 37°C with 8% CO2 without shaking. 
After 24 h, the culture medium was exchanged with fresh 293FreeStyle medium 
containing 50 μg mL-1 of geneticin sulfate to select for transfectants. Individual 
clones were isolated into 96-well plates and maintained in pre-conditioned 
293FreeStyle medium before transfer into increasingly larger culture vessels. Cell 
stocks were prepared in 293FreeStyle medium containing 5% dimethylsulfoxide 
and frozen overnight at -80°C in a slow-freezing container before submersion in 
liquid N2 for long-term storage. In total, ten lines were generated with varying 
degrees of mCherry fluorescence. The HEK293-8D3 clone used in Anl labeling 
experiments displayed a median value of mCherry fluorescence relative to the 
other lines generated, and was selected on the basis of growth rate (within 10% 
of the parent line) and high viability. 
 
Cell Culture Maintenance 
Cell stocks of HEK293-8D3 and non-transfected HEK293-F prepared as 
described above were thawed and plated in T-75 flasks containing 15 mL of low-
glucose Dulbeccoʼs Modified Eagle Medium containing 10% fetal bovine serum 
(FBS), penicillin, and streptomycin. After 48 h, geneticin sulfate was added to the 
HEK293-8D3 culture to a final concentration of 50 μg mL-1. The cultures were 
maintained in this medium (and with 50 μg mL-1 geneticin in the case of HEK293-
8D3) at 37 °C, with 5% CO2 using standard procedures. 
 
Analysis of the NLL-EcMetRS from HEK 293F-8D3 Cells 
To collect soluble cytoplasmic proteins, HEK293-8D3 cells were lysed in 1% (v/v) 
Triton-X100 solution in PBS with protease inhibitors. The N-terminally His-tagged 
NLL-MetRS-mCherry was purified from the lysate of HEK293-8D3 cells using 
magnetic Ni-NTA agarose beads (Qiagen) according to the manufacturerʼs 
protocol.  As a control, the purification was also performed using a lysate of non-
transfected HEK293 cells. Proteins were analyzed by separation on 9% 
polyacrylamide SDS-PAGE gels and stained using Coomassie Brilliant Blue G-
250. We confirmed that the protein purified from HEK293-8D3 cells was indeed 
NLL-MetRS-mCherry by in-gel tryptic digestion of the gel fragment containing the 
band and LC/MS/MS analysis of extracted peptides as described in subsequent 
sections. 
 
Western Blotting  
Western blots were performed using standard procedures. Antibodies were used 
at the concentrations suggested by the manufacturers. Mouse monoclonal anti-
GAPDH, mouse monoclonal anti-p53, and mouse monoclonal anti-β-actin were 
from Sigma-Aldrich. Rabbit polyclonal anti-DsRed (for mCherry detection) was 
from Clontech. Rabbit monoclonal anti-histone H4 (pan) was from Millipore. Anti-
PentaHis-AlexaFluor647 conjugate was from Qiagen. Secondary antibodies 
included rabbit anti-mouse AlexaFluor647 conjugate from Invitrogen, and goat 
anti-rabbit DyLight680 conjugate from Cell Signaling Technology. Streptavidin-
AlexaFluor488 and Streptavidin-AlexaFluor647 conjugates were from Invitrogen. 
Antibody and streptavidin conjugates were detected by fluorescence scanning on 
a GE Healthcare Typhoon Trio+. Mass estimates were made by comparison to 
the SeeBlue Plus2 molecular weight marker from Invitrogen. 
 
Model GFP Expression and Purification 
E. coli strain DH10B (Invitrogen) transformed with pJS2-NLL (for GFP containing 
a single Anl) or pJTN5 (for DHFR) (5) as well as the repressor plasmid pREP4 
(Qiagen) were grown overnight in 5 mL LB-broth containing 100 mg L-1 ampicillin 
and 35 mg L -1 kanamycin. The following day cells were diluted 1:50 into M9 
minimal medium supplemented with 40 mg L-1 of each of the 20 amino acids, 1 
mM MgSO4, 0.1 mM CaCl2, 30 mg L-1 thiamine hydrochloride, and 0.4% (w/v) 
glucose. When the culture reached an OD600 of ~1.0, cells were collected by 
centrifugation at 8,000 x g for 5 m at 4° C and washed twice with chilled 0.9% 
NaCl (w/v) solution. Subsequently, cells were resuspended in either fresh M9 
medium (as described above), or M9 medium containing 1 mM Anl in place of 
Met. To induce protein synthesis, IPTG was added to each culture to a final 
concentration of 1 mM. The cultures were incubated at 37 °C with 250 rpm 
shaking for 4 h. Cells were collected by centrifugation and stored at -20 °C. The 
next day, the Met- and Anl-containing model proteins were affinity purified under 
native conditions using Ni-NTA Agarose (Qiagen) according to the 
manufacturerʼs protocol. Purified proteins were buffer exchanged into PBS using 
PD-10 Desalting Columns (GE Healthcare) and normalized by protein 
concentration before use. 
 
Model Protein Enrichment 
The purified GFP containing a single Anl or Met (3 μg) was added to 2 ml of 
HEK293 lysate (prepared as described above) containing 1.5 mg mL-1 protein.  
The mixture was alkylated, modified with DIBAC-biotin, and enriched using 
immobilized streptavidin as described in preceding sections. Western blots and  
Coomassie Brilliant Blue G-250 stained gels and were analyzed using ImageJ. 
 
Mass Spectrometry and Peptide Identification 
Enriched Anl-tagged proteins were separated by 1D SDS-PAGE and gel 
fragments were digested with protease according to previously described 
procedures (7). Extracted peptides were dried under rotary vacuum and 
resuspended in 0.1% formic acid in water (v/v) before analysis on a Thermo 
Scientific LTQFT mass spectrometer. MS/MS samples were analyzed using 
Mascot (Matrix Science). Mascot was set up to search the 
IPI_human_wDEC.v3.54j database (151385 entries) assuming the digestion 
enzyme trypsin or chymotrypsin. Mascot was searched with a fragment ion mass 
tolerance of 0.50 Da and a parent ion tolerance of 10.0 ppm. The iodoacetamide 
alkylation of cysteine was specified in Mascot as a fixed modification. Oxidation 
of methionine, replacement of Met by Anl, and various Anl derivatives (see SI) 
were specified in Mascot as variable modifications. Scaffold (version 
Scaffold_3_00_07, Proteome Software) was used to validate MS/MS based 
peptide and protein identifications. Peptide identifications were accepted if they 
could be established at greater than 90.0% probability as specified by the 
Peptide Prophet algorithm (8).  Protein identifications were accepted if they could 
be established at greater than 90.0% probability and contained at least 2 
identified peptides.  Protein probabilities were assigned by the Protein Prophet 
algorithm (9). Proteins that contained similar peptides and could not be 
differentiated based on MS/MS analysis alone were grouped to satisfy the 
principles of parsimony. 
 
Sub-cellular Fractionation 
Cells pulse-labeled with Anl for 4 h were collected as described earlier. 
Fractionation was performed using the Qproteome Cell Compartment Kit 
(Qiagen). Proteins were precipitated from the cytoplasmic and nuclear fractions 
and by chloroform-methanol and resuspended in 100 mM Tris, pH 8.0 containing 
0.2% (w/v) SDS. Proteins were alkylated and treated with DIBAC-TAMRA as 
described above. Cytosolic and nuclear fractions were compared to total protein, 
which was prepared by lysing cells in RIPA buffer (supplemented with SDS to a 
final concentration of 0.2% (w/v) from a 10% (w/v) solution in water) followed by 
sonication. Proteins were alkylated and modified with DIBAC-TAMRA as 
described in preceding sections. 
 
Histone Extraction 
Frozen HEK298-8D3 cell pellets were resuspended in 3 mL PBS containing 0.5% 
(v/v) Triton X-100 and eComplete EDTA-free protease inhibitor cocktail (1 tablet 
per 50 mL).  Cells were lysed by pipetting and agitation and incubated on ice for 
10 m. Nuclei were collected by centrifugation at 2,000 x g for 10 m at 4° C. The 
supernatant was removed and pelleted nuclei were resuspended in an additional 
1.5 mL of the lysis solution before centrifugation again. Histones were extracted 
from the nuclear pellet by resuspension in 500 µL of 0.2 N HCl followed by 
rotation overnight at 4 °C. The following day, nuclear debris was sedimented at 
2,000 x g for 10 m at 4 °C and the histone-containing supernatant was collected. 
The solution pH was raised by addition of an equal volume of 1 M Tris pH 8.0 
containing 1% (w/v) SDS. Proteins were alkylated and modified with DIBAC-
TAMRA as described in preceding sections. 
 
MetAP Enzymatic Assay 
The fluorogenic substrates Met-AMC (Enzo Life Sciences) and Anl-7-amino-4-
methylcoumarin (custom synthesis from Anaspec) were used in kinetic assays 
with purified recombinant human MetAP-2 2 (Enzo Life Sciences). Reactions 
were performed in black 96-well plates in 30 mM HEPES buffer (pH 7.4, 150 mM 
NaCl, 100 μM CoCl2). Substrate was added to each reaction well at 
concentrations between 0 - 1000 μM. To ensure substrate solubility, each 
reaction contained DMSO at a final concentration of 4%. Reactions were initiated 
by addition of 1 μL of MetAP-2 from a 0.5 mg/mL stock. The increase in AMC 
fluorescence was measured with excitation at 380 nm and emission detection at 
460 nm using a Tecan Safire II fluorescence plate reader. Triplicate 
measurements were averaged and fit to the Michaelis-Menten equation using 
Origin software. 
 
Fumagillin Treatment 
Cells were pulse-labeled with 1 mM Anl for 4 h in the absence or presence of 200 
nM of the irreversible MetAP-2 inhibitor fumagillin (Sigma-Aldrich). Following the 
pulse, cells were collected and Anl-labeled proteins were modified with DIBAC-
TAMRA and analyzed by in-gel fluorescence scanning as described in preceding 
sections. 
 
  
Sequence of the Mutant Synthetase Gene: 
 
His6-NLL-EcMetRS-mCherry 
 
ATGAGAGGATCGCATCACCATCACCATCACGGATCCATGACTCAAGTCGCGAAGAAAATTCTGGTGACGTGCGCAAACC
CGTACGCTAACGGCTCAATCCACCTCGGCCATATGCTGGAGCACATCCAGGCTGATGTCTGGGTCCGTTACCAGCGAAT
GCGCGGCCACGAGGTCAACTTCATCTGCGCCGACGATGCCCACGGTACACCGATCATGCTGAAAGCTCAGCAGCTTGGT
ATCACCCCGGAGCAGATGATTGGCGAAATGAGTCAGGAGCATCAGACTGATTTCGCAGGCTTTAACATCAGCTATGACA
ACTATCACTCGACGCACAGCGAAGAGAACCGCCAGTTGTCAGAACTTATCTACTCTCGCCTGAAAGAAAACGGTTTTAT
TAAAAACCGCACCATCTCTCAGCTGTACGATCCGGAAAAAGGCATGTTCCTGCCGGACCGTTTTGTGAAAGGCACCTGC
CCGAAATGTAAATCCCCGGATCAATACGGCGATAACTGCGAAGTCTGCGGCGCGACCTACAGCCCGACTGAACTGATCG
AGCCGAAATCGGTGGTTTCTGGCGCTACGCCGGTAATGCGTGATTCTGAACACTTCTTCTTTGATCTGCCCTCTTTCAG
CGAAATGTTGCAGGCATGGACCCGCAGCGGTGCGTTGCAGGAGCAGGTGGCAAATAAAATGCAGGAGTGGTTTGAATCT
GGCCTGCAACAGTGGGATATCTCCCGCGACGCCCCTTACTTCGGTTTTGAAATTCCGAACGCGCCGGGCAAATATTTCT
ACGTCTGGCTGGACGCACCGATTGGCctgATGGGTTCTTTCAAGAATCTGTGCGACAAGCGCGGCGACAGCGTAAGCTT
CGATGAATACTGGAAGAAAGACTCCACCGCCGAGCTGTACCACTTCATCGGTAAAGATATTGTTTACTTCctgAGCCTG
TTCTGGCCTGCCATGCTGGAAGGCAGCAACTTCCGCAAGCCGTCCAACCTGTTTGTTCATGGCTATGTGACGGTGAACG
GCGCAAAGATGTCCAAGTCTCGCGGCACCTTTATTAAAGCCAGCACCTGGCTGAATCATTTTGACGCAGACAGCCTGCG
TTACTACTACACTGCGAAACTCTCTTCGCGCATTGATGATATCGATCTCAACCTGGAAGATTTCGTTCAGCGTGTGAAT
GCCGATATCGTTAACAAAGTGGTTAACCTGGCCTCCCGTAATGCGGGCTTTATCAACAAGCGTTTTGACGGCGTGCTGG
CAAGCGAACTGGCTGACCCGCAGTTGTACAAAACCTTCACTGATGCCGCTGAAGTGATTGGTGAAGCGTGGGAAAGCCG
TGAATTTGGTAAAGCCGTGCGCGAAATCATGGCGCTGGCTGATCTGGCTAACCGCTATGTCGATGAACAGGCTCCGTGG
GTGGTGGCGAAACAGGAAGGCCGCGATGCCGACCTGCAGGCAATTTGCTCAATGGGCATCAACCTGTTCCGCGTGCTGA
TGACTTACCTGAAGCCGGTACTGCCGAAACTGACCGAGCGTGCAGAAGCATTCCTCAATACGGAACTGACCTGGGATGG
TATCCAGCAACCGCTGCTGGGCCACAAAGTGAATCCGTTCAAGGCGCTGTATAACCGCATCGATATGAGGCAGGTTGAA
GCACTGGTGGAAGCCTCTAAAACCCGGGATCCACCGGTCGCCACCATGGTGAGCAAGGGCGAGGAGGATAACATGGCCA
TCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGG
CGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGAC
ATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGT
CCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTC
CCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAG
AAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGC
TGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGG
CGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCC
GAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAG  
 
Plasmid map of the pmCherry-N1-His6-EcNLL-MetRS vector: 
 
EcNLL-MetRS 655...2299
His-tag 619...654
613 XhoI (1)
CMV promoter 11...586
2300 XmaI (1)
mCherry 2300...3033
3033 NotI (1)
Kan/neoR 4265...5056
SV40 early promoter 4031...4227
F1 origin 3720...3414
ColE1 5588...6270
pmCherry-N1-
His6-NLL-EcMetRS
6366 bp
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